Northern Trust Corp Nevro Corp Transaction History

Northern Trust Corp

$600 Billion
Q3 2024

A detailed history of Northern Trust Corp transactions in Nevro Corp stock. As of the latest transaction made, Northern Trust Corp holds 349,675 shares of NVRO stock, worth $1.32 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

349,675

Previous 335,370 4.27%

Holding current value

$1.32 Million

Previous $2.82 Million 30.89%

% of portfolio

0.0%

Previous 0.0%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$4.71 - $10.1 $67,376 - $144,480	14,305 Added 4.27%	349,675 $1.95 Million
Q2 2024 Aug 14, 2024	SELL	$7.96 - $13.59 $155,355 - $265,236	-19,517 Reduced 5.5%	335,370 $2.82 Million
Q1 2024 May 14, 2024	SELL	$13.56 - $20.78 $58,335 - $89,395	-4,302 Reduced 1.2%	354,887 $5.12 Million
Q4 2023 Feb 13, 2024	BUY	$14.18 - $22.31 $396,898 - $624,456	27,990 Added 8.45%	359,189 $7.73 Million
Q3 2023 Nov 13, 2023	SELL	$18.22 - $25.85 $37,132 - $52,682	-2,038 Reduced 0.61%	331,199 $6.37 Million
Q2 2023 Aug 11, 2023	SELL	$22.62 - $39.32 $67,158 - $116,741	-2,969 Reduced 0.88%	333,237 $8.47 Million
Q1 2023 May 15, 2023	BUY	$30.17 - $41.11 $54,275 - $73,956	1,799 Added 0.54%	336,206 $12.2 Million
Q4 2022 Feb 13, 2023	BUY	$36.43 - $49.4 $643,572 - $872,700	17,666 Added 5.58%	334,407 $13.2 Million
Q3 2022 Nov 14, 2022	SELL	$40.66 - $53.03 $116,450 - $151,877	-2,864 Reduced 0.9%	316,741 $14.8 Million
Q2 2022 Aug 12, 2022	SELL	$40.85 - $77.67 $369,284 - $702,136	-9,040 Reduced 2.75%	319,605 $14 Million
Q1 2022 May 13, 2022	SELL	$59.95 - $92.06 $856,265 - $1.31 Million	-14,283 Reduced 4.17%	328,645 $23.8 Million
Q4 2021 Feb 08, 2022	SELL	$81.07 - $121.29 $1.39 Million - $2.07 Million	-17,103 Reduced 4.75%	342,928 $27.8 Million
Q3 2021 Nov 15, 2021	SELL	$101.99 - $166.36 $284,042 - $463,312	-2,785 Reduced 0.77%	360,031 $41.9 Million
Q2 2021 Aug 13, 2021	SELL	$141.6 - $179.06 $3.6 Million - $4.55 Million	-25,414 Reduced 6.55%	362,816 $60.2 Million
Q1 2021 May 12, 2021	SELL	$132.81 - $182.18 $8.01 Million - $11 Million	-60,310 Reduced 13.45%	388,230 $54.2 Million
Q4 2020 Feb 11, 2021	SELL	$138.17 - $184.34 $578,655 - $772,015	-4,188 Reduced 0.93%	448,540 $77.6 Million
Q3 2020 Nov 16, 2020	SELL	$114.09 - $145.51 $1.58 Million - $2.02 Million	-13,873 Reduced 2.97%	452,728 $63.1 Million
Q2 2020 Aug 14, 2020	BUY	$89.45 - $129.85 $5.8 Million - $8.42 Million	64,836 Added 16.14%	466,601 $55.7 Million
Q1 2020 May 14, 2020	BUY	$70.23 - $144.31 $1.12 Million - $2.3 Million	15,933 Added 4.13%	401,765 $40.2 Million
Q4 2019 Feb 14, 2020	SELL	$76.41 - $117.54 $900,721 - $1.39 Million	-11,788 Reduced 2.96%	385,832 $45.4 Million
Q3 2019 Nov 13, 2019	BUY	$61.52 - $91.1 $1 Million - $1.48 Million	16,266 Added 4.27%	397,620 $34.2 Million
Q2 2019 Aug 13, 2019	BUY	$58.04 - $66.99 $1.12 Million - $1.29 Million	19,214 Added 5.31%	381,354 $24.7 Million
Q1 2019 May 13, 2019	SELL	$35.52 - $62.62 $319,537 - $563,329	-8,996 Reduced 2.42%	362,140 $22.6 Million
Q4 2018 Feb 12, 2019	SELL	$35.43 - $56.29 $115,820 - $184,012	-3,269 Reduced 0.87%	371,136 $14.4 Million
Q3 2018 Nov 14, 2018	BUY	$44.22 - $75.47 $373,437 - $637,344	8,445 Added 2.31%	374,405 $21.3 Million
Q2 2018 Sep 18, 2018	SELL	$72.38 - $92.5 $137,304 - $175,472	-1,897 Reduced 0.52%	365,960 $29.2 Million
Q2 2018 Aug 14, 2018	BUY	$72.38 - $92.5 $2.96 Million - $3.78 Million	40,896 Added 12.51%	367,857 $29.4 Million
Q1 2018 May 09, 2018	BUY	$69.46 - $88.57 $159,341 - $203,179	2,294 Added 0.71%	326,961 $28.3 Million
Q4 2017 Feb 14, 2018	SELL	$65.94 - $93.31 $694,414 - $982,647	-10,531 Reduced 3.14%	324,667 $22.4 Million
Q3 2017 Nov 13, 2017	BUY	$80.87 - $91.08 $27.1 Million - $30.5 Million	335,198	335,198 $30.5 Million

Others Institutions Holding NVRO

# of Institutions

151

Shares Held

39.3M

Call Options Held

67.9K

Put Options Held

1.59M

View Full List

About NEVRO CORP

Ticker NVRO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,387,800
Market Cap $133M
Description
Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...

More about NVRO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account

Northern Trust Corp Nevro Corp Transaction History